Financial Performance: Revenue, earnings, and profitability directly impact investor confidence and stock price.

Clinical Trial Results: Positive outcomes from clinical trials boost investor optimism, while failures negatively affect the price.

Regulatory Approvals: FDA approvals for ONCO.US products often lead to significant price increases.

Competition: The presence of competing therapies and companies impacts market share and revenue projections.

Market Conditions: Broader economic trends, industry sentiment, and overall market volatility affect stock valuations.

Partnerships and Acquisitions: Strategic collaborations or acquisitions can signal growth potential and raise stock value.

News and Public Perception: Media coverage, analyst ratings, and public opinion influence investor behavior.

Management Team: The competence and experience of the leadership team contribute to investor trust.

Intellectual Property: Strength and protection of patents and intellectual property rights affect long-term prospects.